<code id='A6B4467C8A'></code><style id='A6B4467C8A'></style>
    • <acronym id='A6B4467C8A'></acronym>
      <center id='A6B4467C8A'><center id='A6B4467C8A'><tfoot id='A6B4467C8A'></tfoot></center><abbr id='A6B4467C8A'><dir id='A6B4467C8A'><tfoot id='A6B4467C8A'></tfoot><noframes id='A6B4467C8A'>

    • <optgroup id='A6B4467C8A'><strike id='A6B4467C8A'><sup id='A6B4467C8A'></sup></strike><code id='A6B4467C8A'></code></optgroup>
        1. <b id='A6B4467C8A'><label id='A6B4467C8A'><select id='A6B4467C8A'><dt id='A6B4467C8A'><span id='A6B4467C8A'></span></dt></select></label></b><u id='A6B4467C8A'></u>
          <i id='A6B4467C8A'><strike id='A6B4467C8A'><tt id='A6B4467C8A'><pre id='A6B4467C8A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:6447
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images

          Is this the end of the line for the “pharma bro” with the perpetual smirk?

          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

          advertisement

          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Heart disease and mental health: A look at cardiac psychology
          Heart disease and mental health: A look at cardiac psychology

          MargeryQuackenbush,an85-year-oldpsychoanalyst,inherUpperEastSideapartmentinNewYork.OliviaFalcignofor

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          JPM 2024: Verve Therapeutics looks to mainstream genome editing

          VerveTherapeuticsCEOSekarKathiresanVerveSANFRANCISCO—Thepromiseofgenomeeditinghasgivenrisetopotentia